Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry

Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.

Hunt AR, Nguyen V, Creuzot-Garcher CP, Alforja S, Gabrielle PH, Zarranz-Ventura J, Guillemin M, Fraser-Bell S, Casaroli Marano RP, Arnold J, McAllister IL, O’Toole L, Gillies MC, Barthelmes D, Mehta H.

Br J Ophthalmol. 2021 Mar 12:bjophthalmol-2020-318491. doi: 10.1136/bjophthalmol-2020-318491. Online ahead of print.

PMID: 33712484